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We have previously coupled stable isotope dimethyl labeling with IMAC enrichment for
quantifying the extent of protein phosphorylation in vivo. The enhanced a1 signal of
dimethylated peptides served as a unique mass tag for unequivocal identification of the
N-terminal amino acids. In this study, we demonstrate that the a1 ion could further assist in
mapping the precise phosphorylation site near the N-terminal region and allow the determi-
nation of the exact site and level of phosphorylation in one step by stable isotope dimethyl
labeling. We show that the a1 ion signal was suppressed for dimethylated peptides with a
phosphorylation site at the N-terminus Ser/Thr residue (N-p*Ser/Thr) but was still enhanced
for N-terminus Tyr residue (N-p*Tyr) or internal Ser/Thr residues (-p*Ser/Thr). Based on the
dominant de-phosphorylated molecular ions and b-H3PO4 ions for N-p*Ser/Thr, we propose
that dimethyl labeling increases the basicity of the N-terminus and accelerates the de-
phosphorylation for N-p*Ser/Thr precursors, which, however, suppresses the a1 ion enhance-
ment due to the resulting unsaturated covalent bond on C of the N-terminus amino acid.
Using this method, we excluded three Ser/Thr phosphorylation sites in A431 cells, two of
which, however, were previously reported to be phosphorylation sites; we confirmed three
known phosphorylation sites in A431 cells and quantified their ratios upon EGF treatment.
Notably, we identified a novel phosphorylation site on Ser43 residue at N-terminus of the
tryptic peptide derived from SVH protein in pregnant rat uteri. SVH protein has not been
reported or implied with any phosphorylation event, and our data show that the Ser43 of
SVH is an intrinsic phosphorylation site in pregnant rat uteri and that its phosphorylation
level was slightly decreased upon c-AMP treatment. (J Am Soc Mass Spectrom 2010, 21,
460–471) © 2010 American Society for Mass SpectrometryReversible protein phosphorylation is crucial formany regulatory and functional features ofliving organisms such as intercellular communi-
cation, cell growth, proliferation, differentiation, and
apoptosis [1–4]. For proteins containing multiple phos-
phorylation sites, each phosphorylation site could be
regulated by different kinases and involved in diverse
signal transduction pathways in eukaryotic cells. Thus,
identification of the exact site and the extent of phos-
phorylation are crucial for understanding the role of
dynamic protein phosphorylation. Traditionally, pro-
tein phosphorylation sites are determined by Edman
sequencing coupled with 32P labeling [5–7]. The use of
radioisotopes provides a sensitive detection method,
but it also suffers from the hazard of radioactivity [8, 9].
In recent years, tandem mass spectrometry (MS/MS)
integrated with database searches or de novo sequenc-
ing for protein identification has become an excellent
tool. Coupled with various enrichment techniques, such
as immobilized metal affinity chromatography (IMAC)
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MS-based approach is becoming promising for qualita-
tive and quantitative analyses of phosphoproteins.
However, many challenges still remain for MS-based
phosphoproteomics because peptides are phosphory-
lated at sub-stoichiometric levels. At such low amounts,
signal suppression effects by non-phosphopeptides and
difficulties in achieving full coverage of long tryptic
peptides hinder MS-based phosphoproteomic analysis
[10–13]. In addition, post-translation modification is not
included in the genome database, thus hampering the
identification of exact phosphorylation sites by data-
base assisted methods. Determination of exact phos-
phorylation sites among multiple possible phosphory-
lation sites within a given peptide fragment is difficult
under collision induced dissociation (CID) of the
MS/MS mode due to incomplete fragmentation and
partial dephosphorylation. Such ambiguous assign-
ments are more serious for potential sites centralized in
either N- or C-terminal since they are more clearly
identified by same types of fragments, b and y ions,
respectively. Although electron-transfer dissociation
(ETD) [14–16] could provide better backbone fragmen-
tation than the CID method, ETD has limitations for
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far more robust and more frequently used for protein
identification.
Many noteworthy chemical approaches have been
developed to assist in identifying protein phosphoryla-
tion sites. For instance, Knight et al. used -elimination
of phosphate groups with a barium catalyst in sodium
hydroxide followed by Michael addition with cysteam-
ine to convert phosphoserine and phosphothreonine
into lysine analogues, which could be recognized and
cleaved with endoproteinase Lys-C. Due to the diaste-
reomeric aminoethylcysteine (R/S) peptide mixture
generated by the reaction, cleavages only occur on the R
isomeric form of the lysine analogue. Such partial
cleavage creates a ladder of peptides consisting of
successive single cleavage and, together with the
unique y1 mass tag associated with the converted lysine
analogue, can be used to assist in identifying protein
phosphorylation sites [17, 18]. Kristensen et al. also
reported a strategy using uranyl (VI) photocleavage to
recruit the phosphopeptides by affinity interaction be-
tween uranyl ion and the phosphate group and then
cleave at N-proximal to the phosphorylated residues by
irradiation at 320 nm. The phosphorylation site could
then be identified by MS via such site specific cleavage
[19]. There are, however, one or two drawbacks associ-
ated with these methods, including complex and labo-
rious processes and long cleavage fragments that are
hard to analyze by MS.
We have previously coupled stable isotope dimethyl
labeling with IMAC enrichment for quantifying the
extent of protein phosphorylation in rat uteri, and the
enhanced a1 signal of dimethylated peptides serves as a
unique mass tag for unequivocal identification of N-
terminal amino acids [20, 21]. Compared with other
labeling methods, this labeling reaction is fast (less
than 5 min) and does not produce any detectable by-
products. In this study, we further explore how the a1
ion could assist in mapping the precise site of phos-
phorylation at N-terminus Ser/Thr and Tyr residue and
allow the determination of the exact site and the level of
phosphorylation in one step by stable isotope dimethyl
labeling. We will characterize the fragmentation by
standard phosphopeptides and then demonstrate the
usefulness of the method by qualitatively and quanti-
tatively analyzing phosphoproteins stimulated by
MARK and PKA kinases in cells and tissues. Based on
the observations, we have proposed fragmentation
pathways that could explain the results.
Experimental
Materials
Acetonitrile, ammonium hydroxide, acetic acid, and
formaldehyde (37% in H2O) were purchased from J. T.
Baker (Phillipsburg, NJ, USA). Trichloroacetic acid
(TCA), formic acid (98%  100%), iron(III) chloride, so-dium acetate, ammonium bicarbonate, and sodium chlo-
ride were obtained from Riedel-de Haven (Seelze, Ger-
many). D,L-dithiothreitol (DTT), sodium cyanoborohydride.
The synthetic peptides, SSpSPAPADIAQTVQEDLR and
pSSSPAPADIAQTVQEDLR were purchased from Sigma
(St. Louis, MO, USA); pTQTPPVSPAPQPTEER and
pYLLNQGADVTLR were synthesized by MDBio (Taipei,
Taiwan). Formaldehyde-D2 was obtained from Aldrich
(Milwaukee, WI, USA). Iodoacetamide (IAM) and tryp-
sin were purchased from Fluka (Buchs, Switzerland)
and Promega (Madison, WI, USA), respectively. The
water was from an E-pure water purification system
(Barnstead Thermolyne Corp., Dubuque, IA, USA).
Cell Culture and Rat Uterus Homogenate
A431 cells were cultured in Dulbecco’s modified Eagle’s
medium (Sigma-Aldrich, Louis, MO. USA) supple-
mented with 10% fetal bovine serum, penicillin/
streptomycin (Gibco/Invitrogen, Carlsbad, CA, USA)
and 5% CO2 at 37 °C. Cells were cultured for an
additional 24 h in the absence of serum and then treated
with 50 ng/mL of EGF (Upstate Biotechnology,
Waltham, MA, USA) for 20 min at 37 °C. After the
treatment, cells were washed two times with ice-cold
PBS and then were lysed in modified RIPA buffer
containing 50 mM Tris-HCl, 1% NP40, 0.25% sodium
deoxycholate, 150 mMNaCl, 1 mM EGTA, 1 mM PMSF,
1 g/mL aprotinin, 1 g/mL leupeptin, 1 g/mL
pepstatin, 1 mMNaF, and 1 mM sodium orthovanadate
at pH 7.4. Uterus homogenate of female Wistar rats (ca.
200–350 g) sacrificed on gestation d 18 was prepared
and analyzed as described in a previous study [22].
IMAC and Dimethyl Labeling
Cell lysate (500 g total protein) or uterus homogenate
(1 mg total protein) was reduced with 10 mM DTT at
95 °C for 5 min. The sample was then alkylated with 50
mM IAM (A431 cells) or IAA (uterus homogenate) in
the dark at room temperature for 30 min and then
concentrated by TCA precipitation. After washing with
10% TCA and deionized water, 4 g trypsin dissolved
in 200 L of 50 mM ammonium bicarbonate (pH 7.8)
was added and left to react at 37 °C for 18 h. A slurry of
POROS MC20 (Applied Biosystems, Foster city, CA,
USA) in deionized water was packed under vacuum
into a 31.6 L cartridge. After equilibration with 0.1%
acetic acid, the packed cartridge was filled with 25 mM
iron (III) chloride in 0.75 M sodium acetate, and was
then reconditioned with 0.1% acetic acid before use. The
tryptic digests were loaded into the prepared IMAC
cartridge, washedwith two buffers in sequence, the buffer
containing 0.1% acetic acid and 30% ACN, and then the
buffer containing 0.1% acetic acid for a total of six car-
tridge volumes. The digests were then elutedwith a buffer
containing 0.5% ammonium hydroxide (pH 9.5). The
eluted fractions were dried under vacuum. The phos-
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tides (100 pmol) were diluted with 100 L of sodium
acetate buffer (100 mM, pH 5.6). The solution was then
mixed with formaldehyde (4% in water, 4 L), vortexed,
and then mixed immediately with freshly prepared so-
dium cyanoborohydride (600mM, 4L). Themixture was
vortexed again and then allowed to react for 5 min.
Finally, ammonium hydroxide (4% in water, 4 L) was
added to consume the excess formaldehyde. After desalt-
ing and drying, the samples were redissolved in a buffer
containing 5% acetonitrile and 0.1% formic acid for LC/
MS/MS analysis.
Instrumentation
For labeling efficiency, the MS data were obtained
using a MALDI-TOF spectrometer equipped with a
337-nm N2 laser (MALDI, Micromass, Manchester,
U.K.). The MALDI matrix was prepared by dissolving
4-cyanohydroxysuccinic acid (10 mg) in EtOH/MeCN
(1:1, 1 mL) containing 0.1% TFA. A 0.5 M solution of HCl
was mixed with both the matrix and the 400 fmol/L
phosphopeptides at a ratio of matrix/HCl/sample of 2:1:1
(vol/vol/vol). The mixture was deposited on the target
and dried before detection. For protein identification by
peptide sequencing, the samples were analyzed by a
Q-TOF micro spectrometer (Micromass, Manchester,
UK) by direct infusion at a flow rate of 0.3 L/min or
through an on-line nanoflow HPLC system (LC Pack-
ings, Amsterdam, The Netherlands). Briefly, a volume
of 25 L tryptic digest solution was injected, concen-
trated by a C18 nanoprecolumn cartridge (i.d. 300 m
1-mm, 5-m C18, P/N160458, LC Packings), and then
separated by a C18 column (i.d. 75 m, o.d. 280 m 
15-cm, 3-m C18, LC Packings). Mobile phase A con-
sisted of 0.1% formic acid in 5% acetonitrile solution,
and mobile phase B consisted of 0.1% formic acid in
80% acetonitrile solution; a linear gradient from 5% to
90% B over a 60 min period at a flow rate of 250 nL/min
was applied. The parameters set on the Q-TOF micro
instrument were as follows: capillary voltage (3000 V),
sample cone (60 V), excitation cone (0.5 V), source
temperature (80 °C), and collision energy (30–50 V).
The MassLynx 4.0 Global ProteinLynx was used to
produce a peak list from raw data. The MS/MS spectra
were obtained by performing survey scans; the survey
scan was from m/z 400 to 1600, and MS/MS scan was
from m/z 50 to 2000. The threshold to switch fromMS to
MS/MS was 10 counts.
Database Search and Quantification
Proteins were identified using the in-house MASCOT
v2.2.1 search engine on the Swiss-Prot 51.6 (human)
protein database (257,964 sequences; 15,720 human pro-
tein sequence entries) and NCBInr 20060829 (Rattus)
database (3888187 sequences; 40,015 protein sequenceentries) as well as on the random protein database for
validation. The mass tolerance was set to be 0.2 Da for
precursor and 0.2 Da for product ions. Phos(ST),
phos(Y), and oxidation(M) were chosen for variable
modifications; carboxymethyl- (IAA for uterus homog-
enate) or carbamidomethyl (IAM for A431 cells) were
chosen for fixed modifications, and one trypsin mis-
cleavage was allowed. For labeled peptides, dimethyl
(heavy or light) at N-terminal or lysine (k) was added as
the variable modification. We set a score cutoff at 20 to
eliminate low-score peptides, and only “rank1” (best
match for each MS/MS) peptides were included. Only
proteins within the significant hit lists (P  0.05) were
regarded as identified proteins. Under these criteria, the
cut-off scores are 40 and 20 for proteins and peptides,
respectively. Random database search for false identifica-
tion rate was determined to be less than 3.08%. Moreover,
theMS/MS spectra of individual phosphopeptide ion that
reaches a score beyond significant hit (P  0.05) were
manually inspected, and their MS/MS spectra must ex-
hibit de-phosphate molecular ion (98 Da) to be counted
as identified. Details about phosphoproteins identified
fromA431 cells are listed in Table S1 of the supplementary
material, which can be found in the electronic version of
this article. All of the spectra containing both mass peaks
ofD4- andH4-labeled peptides were combined to produce
a composite MS spectrum. The ratios of the D4- and
H4-labeled peptides in the composite MS spectra were
calculated from the sum of the peak heights of the first
three isotopic peaks.
Results and Discussions
Labeling Efficiency for Phosphopeptides
Whether or not the N-terminus phosphorylation affects
the labeling reaction was investigated first since di-
methyl labeling occurs on both the N-terminus and
-amino group of Lys residues via reductive amination.
The spectra obtained from the H4- and D4-labeled, as
well as from the unlabeled N-terminus phosphopep-
tide, pSSSPAPADIAQTVQEDLR sequence derived
from Ras-GTPase-activating protein-binding protein 1,
are shown in Figure 1. The spectra indicate that the m/z
value of the unlabeled ion (Figure 1a) is 28 mass units
lower relative to those of the H4-labeled ion (Figure 1b),
which is consistent with the prediction made by count-
ing a 28-mass-unit difference for each labeled site and
indicates that this labeling reaction is not affected by
N-terminus phosphorylation. Moreover, since no unla-
beled peptides were detected after the reaction, the
labeling efficiency of phosphopeptides is near 100% as
reported for non-phosphopeptides [23] as well as for
tryptic peptides with internal phosphorylation sites
[22]. Figure 1c shows that the D4-labeled ions are 32 and
4 mass units higher relative to the unlabeled and
H4-labeled ions, respectively, which is also consistent
with the prediction. The peaks at around m/z 1986
(Figure 1b) and 1990 (Figure 1c) were due to the labeled
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standard, and their unlabeled ion was indicated in
Figure 1a as impurity peaks at around m/z 1958. It is
also worth noting that the phosphate group was not
modified or cleaved by dimethyl labeling, indicating
that this labeling strategy is applicable for peptides with
N-terminus phosphorylation sites.
MS/MS Spectra for Unlabeled and
Dimethylated Phosphopeptides
Figure 2 displays the MS/MS spectra of the synthetic unla-
beled phosphopeptides with phosphorylation at the N-
terminus Ser residue (N-pSer), pSSSPAPADIAQTVQEDLR
(Figure 2a) as well as at the third Ser residue (-pSer),
SSpSPAPADIAQTVQEDLR (Figure 2b). Both of the
precursor ions are doubly charged, and the N-pSer
sequence appears to have more dephosphorylated mo-
lecular ion [MH2  H3PO4]
2 relative to the –pSer
sequence. In contrast, the –pSer sequence appears to
have more intact molecular ion [MH2]
2 relative to the
N-pSer sequence. The above results could indicate a
higher probability of de-phosphorylation for N-pSer
than for –pSer and worth further investigations. More-
over, as shown in Figure 2a, the fragmentation pattern
of the N-pSer peptide and -pSer peptide appears to be
different. Besides the b2 ion, there is no b1 or y ion to
confirm the exact phosphorylation site among the first
two residues. However, based on the bx-yz low-energy
pathway, the lack of b1 ion is expected due to a
nucleophilic attack by the oxygen of the N-terminus
amide on the second carbon center of the protonated
Figure 1. MALDI spectra of (a) unlabeled N-ter
derived from Ras-GTPase-activating protein-bind
(c) labeled with D4-formaldehyde.amide (pathway B of Scheme 1). Likewise, as shown inFigure 2b, there is [b3 – H3PO4]
 ion for –pSer, but there
is no b2 ion to confirm the exact phosphorylation site
among the first three residues.
The MS/MS spectra of dimethylated phosphopep-
tides with phosphorylation sites at the N-terminus
(*N-pSer/Thr) and internal residues (*-pSer/Thr) were
also investigated. Stable isotope dimethyl labeling is
reported to provide a signal enhancement for the pro-
duced a1 or yn-1 ions, which are usually hard to detect
among most of the nonderivatized fragments. With a
phosphorylation site at the N-terminus (*N-pSer), the a1
signal enhancement was not observed, and with phos-
phorylation sites at internal residues (*-pSer), the a1 frag-
ment of the *-pSer ion was substantially enhanced, as
shown in Figure 3. Likewise, same phenomena were also
observed for peptides labeled with D4 formaldehyde
(Figure S1A and B, supplementary material). Moreover, it
is worth noting that only the de-phosphorylated molecu-
lar ion [MH2  H3PO4]
2 but no intact molecular ion
[MH2]
2 was detected for *N-pSer; in contrast, only the
intact molecular ion [MH2]
2 but no de-phosphorylated
molecular ion [MH2  H3PO4]
2 was detected for *-pSer
(Figure 3b). In addition, all detected b ions were de-
phosphorylated for *N-pSer, but there were still sub-
stantial phosphorylate b ions for *-pSer peptides. Such
results indicate that dimethyl labeling could enhance
de-phosphorylation at N-terminus sites. In addition to
serine, similar results were also observed for threonine
residue with stable isotope dimethyl labeling using H4
(Figure 3c) and D4 (Figure S2, supplementary material)
formaldehyde. As displayed in the spectra, the a1 ion of
*pTQTPPVSPAPQPTEER (*N-pThr) was lacking, and
s phosphopeptide, pSSSPAPADIAQTVQEDLR
rotein 1, (b) labeled withH4-formaldehyde, andminu
ing ponly the dephosphorylated molecular ion [MH2 
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2 was detected. We have also examined the
MS/MS spectra of a dimethylated peptide containing
phospho-tyrosine at N-terminus, *pYLLNQGADVTLR
(*N-pTyr) using H4 (Figure 3d) and D4 (Figure S3, supple-
mentary material) formaldehyde for the labeling. How-
ever, as shown in the spectra, no de-phosphorylated
molecular ion [MH2  H3PO4]
2 was detected, and the
phosphotyrosine at the N-terminus can be unambigu-
ously assigned by the enhanced a1 ion with m/z 244Da.
In addition to the above three (S/T/Y) sequences, we
have investigated other MS/MS spectra acquired from a
Figure 2. MS/MS spectra of the synthetic
terminus Ser residue (N-pSer), pSSSPAPADIAQ
SSpSPAPADIAQTVQEDLR.large scale phosphoproteomics analysis (data not shown).We found no exceptions of MS/MS spectra derived from
N-terminus phosphopeptides (11 cases) and from non-N-
terminus phosphopeptides against the conclusions we
made. Three additional representative MS/MS spectra de-
rived fromN-terminus phosphopeptides were shown in
Figure S4–S6 (supplementary material). Among them, the
spectra derived from *N-pSer [(CH3)2pSPGMLEPLGSSR]
(Figure S4) and *N-pSer [(CH3)2pSGEGEVSGLMR] (Figure
S5)were lack of a1 ion and thedephosphorylatedmolecular/
fragment ions predominantly occurred. On the other hand,
the spectrum of *N-pTyr [(CH3)2pYLYEIAR] (Figure S6)
phopeptides with phosphorylation at (a) N-
EDLR and (b) at the third Ser residue (-pSer),phos
TVQexhibits the enhanced a1 ion and the intact molecular/
465J Am Soc Mass Spectrom 2010, 21, 460–471 MAPPING PHOSPHORYLATION SITE AND QUANTITATIONfragment ions predominantly occurred. Thus,we believe our
conclusion is valid.
Fragmentation Pathway
Our results clearly indicate that dimethyl labeling leads
to enhanced dephosphorylated molecular [MH2 
H3PO4]
2 and [b  H3PO4]
 ions derived from *N-
pSer/Thr precursors but not for either *-pSer/Thr or
*N-pTyr precursors. Possible mechanisms are proposed
as depicted in Schemes 1 and 2 to explain these obser-
vations. By protonation, a tryptic peptide precursor
normally is doubly charged. The charge commonly
resides on the N-terminus and the basic R or K residue
at the C-terminus initially. Dimethyl labeling will
increase the basicity of the N-terminus and thus
further increase the chance of N-terminus protona-
tion. For *-pSer/Thr precursor, as shown in Scheme 1,
the fragmentation occurs as protons mobilize from
Scheme 1. Fragmentation pathways for dimeth
at the internal residues (*-pSer/Thr).the N-terminus to the phosphate group (pathway A)or to the N atom along the main chain (pathway B).
The former will lead to dephosphorylation of the
molecular ion via a charge-directed SN2 neighboring
group participation reaction or a charge-directed E2
elimination reaction [24, 25], which could subse-
quently undergo a sequence of backbone cleavages;
the later will directly lead to backbone cleavages. The
b ions created by backbone cleavages either via
pathways A or B are thus composed of both dephos-
phorylated and phosphorylated b ions, both of which
could lead to stable a1 ions via concerted cleavages at
the C–Camide bonds, as we and other group had
reported previously [20, 26, 27].
For *N-pSer/Thr precursor, we think the increased
basicity of the N-terminus by dimethyl labeling will
substantially diminish the mobility of the charged N-
terminus proton. On the other hand, we think that the
protonated N-terminus will stabilize the product of
-elimination, which occurs between the adjacent C and
d phosphopeptides with phosphorylation sitesylateC by inductive effect and thus enhance the dephosphor-
ADV
466 WU ET AL. J Am Soc Mass Spectrom 2010, 21, 460–471ylation of the N-terminus phosphorylated precursor ion.
Taken together, we proposed a mechanism as depicted in
Scheme 2 under which de-phosphorylation of *N-pSer/
Thr precursors occurs by -elimination via a six-ring
intermediate and this reaction occurs much more rapidly
than proton mobilization, leading to dominant dephos-
phorylated molecular [MH2  H3PO4]
2 and b-H3PO4
ions in MS/MS spectra. Thus, the b ions formed by
backbone fragmentation following the molecular ion
dephosphorylation are also dephosphorylated. How-
Figure 3. MS/MS spectra of dimethylated pho
N-terminus, *pSSSPAPADIAQTVQEDLR and (
with (c) Thr phosphorylation site at N-term
phosphorylation site at N-terminus, *pYLLNQGever, the resulting unsaturated covalent bond on C ofthe N-terminus amino acid of *N-pSer/Thr precursor
could suppress the formation of a1 ions since the
dimethyl-vinylidene-ammonium cation is very unsta-
ble. Thus, no enhanced a1 ion was observed for
*N-pSer/Thr peptides.
Our explanations are consistent with a recent report
[28] in which the magnitude of the neutral loss of
phosphoric acid was found to be highly dependent on
the proton mobility of the precursor ion for both phos-
phoserine- and phosphothreonine-containing peptides.
peptides with a Ser phosphorylation site at (a)
internal residue, *SSpSPAPADIAQTVQEDLR;
*pTQTPPVSPAPQPTEER, and with (d) Tyr
TLR.spho
b) at
inus,In this study [28], peptides with internal phosphoryla-
Co
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charge-remote -elimination reaction does not predom-
inantly occur. In our study, however, peptides with
N-terminus phosphorylation sites were examined and
the dephosphorylation was not through charge-remote
mechanism since the N-terminus charge was spatially
close to the elimination sites. On the other hand, since
dephosphorylation by -elimination will not occur for
peptides containing phosphotyrosine, the *N-pTyr pep-
tides investigated here did not exhibit enhance dephos-
phorylation, and suppressed a1 ions as predicted based
Figure 3.on the above mechanisms.Mapping and Quantifying Phosphorylation
Sites In Vivo
As a proof of concept, from an unfractionated A431 cell
lysate, we found around 15%–20% of identified phos-
phopeptides containing or potentially containing N-
terminus phosphorylation sites. Many of them contain
multiple potential phosphorylation sites near the N-
terminal region. These sites, however, cannot be unam-
biguously confirmed based on either database searches
or de novo sequencing. Stable isotope dimethyl labeling
ntinued.was performed to quantify the phosphorylation level
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spectra of three phosphopeptides derived from Ras-
GTPase-activating protein-binding protein 1 (G3BP1),
-1 catenin (CTN1), and Src substrate cortactin (SRC8),
respectively, along with their corresponding chromato-
grams containing the (D4/H4) isotopic pair are shown in
Figure 4. Apparently, all three MS/MS spectra show
more intact molecular ions [MH2]
2 than the dephos-
phorylated molecular ion [MH2  H3PO4]
2, and all
three MS/MS spectra exhibit enhanced a1 ions (Figure
Scheme 2. Fragmentation pathway for dimethylated phosphopep-
tides with phosphorylation sites at the N-terminus (*N-pSer/Thr).4a, b, and c). Thus, the N-terminus phosphorylation sitecan be excluded for all three phosphopeptides, confirm-
ing the internal phosphorylation sites near the N-
terminal region: pSer 232 for Ras-GTPase-activating
protein-binding protein 1, pThr401 for Src substrate
cortactin, and pSer 641 for -1 catenin. Among these
excluded sites, the site on Ser230 of G3BP1 and the site
on Thr399 of SRC8 proteins were assigned to be phos-
phorylation sites in previous reports [29, 30] without
confirmation. It is worth noting that the synthetic
peptides shown in Figures 2b and 3b without and with
dimethyl labeling, respectively, were the same se-
quence (SSpSPAPADIAQTVQEDLR) derived from
Ras-GTPase-activatingprotein-bindingprotein 1 as shown in
Figure 4a, whereas, unlike those detected from the synthetic
peptides, no y16 or y17 ions (Figure 4a) could be detected
from A431 cells to help in identifying the exact phosphory-
lation site. Likewise, the synthetic peptide shown in Figure 3c
is the same sequence (TQpTPPVSPAPQPTEER) derived
fromSrc substrate cortactin as that displayed in Figure 4bbut
with different phosphorylation sites. Phosphorylation at the
N-terminus (Figure 3c) leads to suppressed a1 ion and
enhanced dephosphorylated molecular and b-H3PO4 ions
compared with that with phosphorylation at the third thre-
onine (Figure 4b). From the corresponding chromatograms
shown in Figure 4, the phosphorylation levels of these
confirmed phosphorylation sites were found to slightly in-
crease by a factor of 1.43 for TQpTPPVpSPAPQPTEER,
1.42 for TPEELDDpSDFETEDFDVR, and 1.23 for
SSpSPAPADIAQTVQEDLR upon EGF stimulation.
The ratio of TQpTPPVpSPAPQPTEER was further
confirmed by reversed labeling as shown in Figure
4b. Furthermore, from unpublished data we obtained
from a previous experiment performed on pregnant
rat uterus homogenate [21], we confirmed a N-
terminus phosphorylation site (pSer 43) for the
pSAEDLTEGSYDAILSAEQLSAEQLEK peptide de-
rived from similar SVH protein (Figure 4d) based on the
suppressed a1 ion and the dominant dephosphorylated
molecular ion [MH2  H3PO4]
2 in its MS/MS spectra.
The phosphorylation level of pSer 43 was shown to
decrease by a factor of 0.79 upon cAMP treatment
(Figure 4d). Although this N-terminus phosphorylation
site can also be identified by the dephosphorylated b ions,
the a1 ion suppression provides a higher confidence and
avoids misassignment due to isobaric mass effects. Nota-
bly, Ser43 is a novel phosphorylation site for the SVH
protein. SVH is a novel Armadillo repeat protein that has
not been reported or implied with any phosphorylation
event. Our data show that the pSer43 of SVH protein is an
intrinsic phosphorylation site in pregnant rat uteri.
Conclusion
We have demonstrated that dimethyl labeling on pep-
tide N-terminus will enhance the dephosphorylation of
the molecular ion and suppress the a1 ion formation
for Ser/Thr phosphorylated peptides with phosphory-
lation site at N-terminus but not for those with phos-
phorylation site at the internal residues. The involved
tio.
469J Am Soc Mass Spectrom 2010, 21, 460–471 MAPPING PHOSPHORYLATION SITE AND QUANTITATIONmechanisms were investigated, and a charge-remote
-elimination and mobile proton theory were proposed
to explain the observations. We have then further
demonstrated that the phosphorylation level and the
exact phosphorylation site near N-terminal region can
be determined simultaneously for phosphoproteins by
stable isotope dimethyl labeling. Using a global analysis
Figure 4. MS/MS spectra of dimethylated phos
protein-binding protein 1 in A431 cells; (b) Src s
A431 cells, (d) SVH protein in pregnant rat
chromatograms of the isotopic pairs for quantific
treatment. For (b), Src substrate cortactin protein
was also shown to confirm the quantification raon A431 cells and uterus tissues as examples, weexcluded the phosphorylation on Ser230 of G3BP1 and
on Thr399 of SRC8 proteins in A431 cells, which were
previously assigned as phosphorylation sites. We have
also confirmed a known phosphorylation site on Ser634
of the CTN1 protein. The EGF-induced phosphorylation
on these sites was also quantified by stable isotope
dimethyl labeling. Furthermore, based on the attenua-
eptides derived from (a) Ras-GTPase-activating
ate cortactin in A431 cells, and (c) -1 catenin in
s tissue. The indents are the corresponding
upon (a), (b), (c) EGF treatment, and (d) c-AMP




, thetion of the a1 ion of dimethylated peptides, we identi-
Co
470 WU ET AL. J Am Soc Mass Spectrom 2010, 21, 460–471fied a novel phosphorylation site on Ser43 residue at the
N-terminus of the tryptic peptide derived from SVH
protein in pregnant rat uteri. We concluded that stable
isotope dimethyl labeling on peptides bears many in-
teresting chemistries that could lead to multiple useful
applications in proteomics analysis.
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